NUCLEIX LTD has a total of 26 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and China. Its main competitors in its focus markets biotechnology, computer technology and medical technology are VALLEY HEALTH SYSTEM, REDPATH INTEGRATED PATHOLOGY I and AVELLINO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 4 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 4 | |
#6 | Canada | 2 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Healthcare informatics | |
#3 | Microorganisms | |
#4 | Electrotherapy | |
#5 | Analysing materials | |
#6 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Wasserstrom Adam | 23 |
#2 | Frumkin Danny | 21 |
#3 | Knirsh Revital | 9 |
#4 | Frumkin Dan | 3 |
#5 | Adam Wasserstrom | 1 |
#6 | Savin Orna | 1 |
#7 | Danny Frumkin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020188561A1 | Methods and systems for detecting methylation changes in dna samples | |
US2020377930A1 | Methods and kits for determining the efficiency of plasma separation from whole blood | |
EP3735472A1 | Kits and methods for detecting cancer-related mutations | |
CN110055313A | Method for diagnosing | |
US9476100B1 | Methods for diagnosing bladder cancer | |
AU2010329552A1 | Categorization of DNA samples | |
WO2009083989A1 | Methods for dna authentication |